WHOAIDS data at 30 June 1995 and the current global situation of the HIV/ AIDS pandemic. Weekly Epidemiological Record1995; 70: 193–200.
2.
European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: Quarterly Report No 44; 31December1994.
3.
Report of an Expert Group (Chairman: Professor N E Day) convened by the Director of the Public Health Laboratory Service on behalf of the Chief Medical Officers. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994. Communicable Disease Report1996; 6: 1.
4.
HIV Infection and AIDS: Quarterly Report to 31 December 1995. ANSWER (AIDS News Supplement to the Weekly Report)1996: AM-19 No 96/04.
5.
AIDS and HIV-1 Infection in the United Kingdom. Communicable Disease Report1996; 6: 7.
6.
MelbyeMFroebelK SMadhokRBiggarR JSarinP SStenbjergSLoweG D OForbesC DGoedertJ JGalloR CHTLV-III seropositivity in European haemophiliacs exposed to factor VIII concentrate imported from the USA. Lancet1984; ii: 1444–46.
7.
LudlamCATuckerJSteelCMHuman T lymphotrophic virus type III (HTLVIII) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet1985; ii: 233–36.
8.
FroebelK SMadhokRForbesCDLennieSLoweGDOSturrockRD. Are the immunological abnormalities in haemophiliacs caused by American factor VIII concentrate? Br Med J1983; 287: 1091–93.
9.
HIV and AIDS Surveillance in Scotland, Review of the Epidemic to December 1994 - ANSWER (AIDS News Supplement to the Weekly Report)December1995: Special Edition.
10.
AIDS and severe HIV-related disease in Scotland - Predictions to the end of 1999. A report by a working group convened by the Chief Medical Officer for Scotland. ANSWER (AIDS News Supplement to the Weekly Report); 1995AM-18 - WR 95/52.
11.
ShiachC RBurtA DIslesC GBallS G. Pyrexia of undetermined origin, diarrhoea and primary cerebral lymphoma associated with acquired immunodeficiency. Br Med J1984; 288: 449–50.
12.
GoedertJ JKesslerC MAledortL MA prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with haemophilia. N Eng J Med1989; 321: 1141–48.
13.
WallP GPorterKNooneAGoldbergD J. Changing incidence of Pneumocystic carinii pneumonia as initial AIDS defining disease in the United Kingdom. AIDS1993; 7: 1523–25.
14.
GoldbergD JEmslieJ ASmythWReidD and collaborating microbiologists. A system for surveillance of voluntary HIV testing; results of the first 2 years, 1989–1990. AIDS1992; 6: 495–500.
15.
FrischerMLeylandACormackRGoldbergD JBloorMGreenS TTaylorACovellRMcKeganeyNPlattS. Estimating population prevalence of injected drug use and HIV infection among injecting drug users in Glasgow. American Journal of Epidemiology1993; 138 (3): 170–81.
16.
TaylorAFrischerMGreenS TGoldbergD JMcKeganeyNGruerL. Low and stable prevalence of HIV among Glasgow drug injectors. International Journal of STD and AIDS1994: 5; 105–107.
17.
Des JarlaisDHaganHFriedmanS RFriedmannPGoldbergD JFrischerMGreenSTunvingKLjungbergBWodakARossMPurchaseDMillsonM EMyersE. Maintaining Low HIV Seroprevalence in Populations of Injecting Drug Users. JAMA1995; 274: No 15: 1226–31.
18.
BirdA GGoreS MCameronSRossA JGoldbergD. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS1995: 7; 801–08.
19.
GoreS MBirdG A. Cross-sectional Willing Anonymous HIV Salivary (WASH) Surveillance studies and self-completion risk factor questionnaire in establishments of the Scottish Prison Service. ANSWER (AIDS News Supplement to the Weekly Report)AM-15 WR 95/39.
20.
TaylorAGoldbergDEmslieJ. Outbreak of HIV infection in a Scottish prison. Br Med J1995: 310; 289–92.
21.
GoreS MBirdA GBurnsS MGoldbergD JRossA JMacgregorJ. Drug injection and HIV prevalence in inmates of Glenochil prison. Br Med J1995; 310: 293–96.
22.
BurnsS MBrettleR PGoreS MPeuthererJ FRobertsonJ R. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. The Journal of Infection1996; 32: 53–62.
23.
RobertsonJ RBucknallABVWelsbyP DInglisJ MPeuthererJ FBrettleR PRobertsJ K. Epidemic of AIDS related virus (HTLV III/ LAV) infection among intravenous drug users. Br Med J1986; 292: 527–29.
24.
SkidmoreC ARobertsonJ RRobertsonA AEltonR A. After the epidemic: follow-up study of HIV seroprevalence and changing patterns of drug use. Br Med J1990; 300: 219–23.
25.
PeuthererJ FEdmondESimmondsPDicksonJ DBathG E. HTLV III antibody in Edinburgh drug addicts. Lancet1985; ii: 1129–30.
26.
BirdA GGoreS MJolliffeD WBurnsS M. Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS1992; 6: 725–33.
27.
BathG EBurnsSDaviesA GDominyNPetersARichardsonA M. HIV prevalence in injecting drug users in Edinburgh. Fewer drug users share needles. Br Med J1993; 306: 1414.
28.
RichardsonA MDaviesA G. Serial Prevalence Study of HIV Infection and HIV Risk Behaviour among Injecting Drug Users in Edinburgh 1992–1994. ANSWER (AIDS News Supplement to the Weekly Report)November1995. AM-17 - WR 95/47.
29.
GoldbergD GGreenS TTaylorAFrischerM. The Heterogeneity of HIV Prevalence among Injecting Drug Users in Europe and the United Kingdom. ANSWER (AIDS News Supplement to the Weekly Report)1994; AM-3 WR 94/39.
30.
UrquhartG E D. An Anonymous HIV Antibody Survey of Drug Problems Centre Attenders in Dundee. Personal communication July1991.
31.
UrquhartG E DScottS SWooldridgeE. Human Immunodeficiency Virus (HIV) in Intravenous Drug Abusers in Tayside. Communicable Diseases Scotland Weekly Report1987; CDS 87/09.
32.
FrischerMElliottLTaylorAGoldbergDGreenS TGruerLCameronJMcKeganeyNBloorM. Do needle exchanges help to control the spread of HIV among injecting drug users? AIDS1993; 7: 1677–78.
33.
RobertsonJ RSkidmoreC ARobertsJ K. HIV infection in intravenous drug users: a follow-up study indicating changes in risk-taking behaviour. British Journal of Addiction1988; 387–91.
34.
BrettleR P. HIV and harm reduction for injection drug users. AIDS1991; 5: 125–36. (Editorial Review).
35.
GruerLCameronJElliottL. Building a city wide service for exchanging needles and syringes. Br Med J1993, 306: 1394–97.
36.
BallADes JarlaisD CDonoghoeM CFriedmanS RGoldbergD JHunterG MStimsonG VWodakA. Multi-City Study on Drug Injecting and Risk of HIV Infection. A report prepared on behalf of the WHO International Collaborative Group. World Health Organisation Publication1994: WHO/PSA/94.4.
37.
FrischerMBloorMGreenSGoldbergD JMcKeganeyNCovellRTaylorA. Reduction in needle sharing among community wide samples of injecting drug users. International Journal of STD and AIDS1992; 3: 288–90.
38.
JohnsonA MWadsworthJWellingKFieldJBradshawW. Sexual attitudes and lifestyles. Oxford: Blackwell Scientific Publications1994.
39.
GoldbergD J. New HIV infections among men who have sex with men, Scotland 1989–1994. ANSWER (AIDS News Supplement to the Weekly Report)1995; AM-8 No. 95/08.
40.
GoldbergDGreenS TTaylorAFrischerMMcKeganeyN. Comparison of four survey methods designed to estimate the prevalence of HIV among female prostitutes who inject drugs. International Journal of STD and AIDS1994: 5; 357–77.
41.
McKeganeyNBarnardMLeylandACooteIFollettE. Female street working prostitution and HIV infection in Glasgow. British Medical Journal1992; 305: 801–804.
42.
ForbesC D. HIV Infection and AIDS - implications for medical care. Scot Med J1988; 33: 291–92.
43.
GoldbergD JMacKinnonHSmithRPrevalence of HIV among childbearing women and those undergoing termination of pregnancy. Br Med J1992; 304: 1082–85.
44.
GillO NAdlerM WDayN E. Monitoring the prevalence of HIV: foundations for a programme of unlinked anonymous testing in England and Wales. Br Med J1989; 299: 1295–98.
45.
Unlinked Anonymous HIV Prevalence Monitoring Programme in England and Wales 1995; Report from the Unlinked Anonymous HIV Surveys Steering Group (Chairman Dr Eileen Rubery, Department of Health).
46.
TappinD MGirdwoodR W AFollettE A CKennedyRBrownA JCockburnF.Prevalence of maternal HIV infection in Scotland, based on unlinked anonymous testing of newborn babies. Lancet1991; 337: 1565–67.
47.
TappinD MGirdwoodR W AFollettE A CKennedyRBrownA JCockburnF. Prevalence of Maternal HIV Infection in Scotland Based on Unlinked Anonymous Testing of Newborn Babies. Update. Scot Med J1993; 38: 16–17.
48.
ScottGGoldbergDWeirMCameronSPeuthererJFollettEHIV prevalence among heterosexuals attending genitourinary clinics in Scotland - the African connection. Submitted.
49.
De VincenziI.A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Eng J Med1994; 331: 341–46.
50.
ConnorE MSperlingR SGelberRKiselevPScottGO'SullivanM JReduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Eng J Med1994; 331: 1173–80.
51.
CrawfordR JMitchellRBurnettS KFollettE A C. Who may give blood? Br Med J1987; 294: 572.
52.
RaesideF JPithieA. HIV infection in the elderly - A care report. ANSWER (AIDS News Supplement to the Weekly Report)1995; AM-12 WR 95/26.
53.
PellJ PGruerL DChristiePGoldbergD. Management of HIV-infected health-care workers: lessons from local experience. Br Med J1996 (in press).
54.
CiesielshiCMarianosDOuC YTransmission of Human Immunodeficiency virus in a dental practice. Annual of Internal Medicine1992; 116: 798–805.
55.
ChooA. Combination superior to Zidovudine in Delta trial (news). Lancet1995; 346: 895.